9 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $73M | -$219M | 0.0% | -340.4% | -$252M | — | $628M |
| 2024 | $35M | -$169M | 0.0% | -595.0% | -$166M | — | $880M |
| 2023 | $27M | -$181M | 0.0% | -704.1% | -$64M | $31M | $526M |
| 2022 | $14M | -$113M | 0.0% | -806.6% | -$105M | $30M | $339M |
| 2021 | $12M | -$67M | 0.0% | -561.0% | -$17M | $30M | $439M |
| 2020 | $10M | -$51M | 0.0% | -500.1% | -$19M | $15M | $0 |
| 2019 | $14M | -$31M | 0.0% | -190.6% | -$30M | — | $0 |
| 2018 | $7M | -$22M | 0.0% | -304.7% | -$27M | — | $0 |
| 2017 | $2M | -$16M | 0.0% | -787.0% | -$3M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $887000 | -$61M | 0.0% | -7382.4% | -$67M | — | $559M |
| Dec '25 | $48M | -$20M | 0.0% | -51.5% | -$20M | — | $628M |
| Sep '25 | $12M | -$59M | 0.0% | -558.6% | -$72M | — | $648M |
| Jun '25 | $3M | -$79M | 0.0% | -2965.8% | -$73M | — | $721M |
| Mar '25 | $10M | -$61M | 0.0% | -703.7% | -$87M | — | $793M |
| Dec '24 | $4M | -$52M | 0.0% | -1824.8% | -$10M | — | $880M |
| Sep '24 | $3M | -$51M | 0.0% | -2385.9% | -$40M | — | $891M |
| Jun '24 | $9M | -$40M | 0.0% | -498.3% | -$45M | $31M | $961M |
| Mar '24 | $20M | -$27M | 0.0% | -162.4% | -$71M | $31M | $457M |
| Dec '23 | $5M | -$49M | 0.0% | -1017.4% | -$47M | $31M | $526M |
| Sep '23 | $5M | -$50M | 0.0% | -949.1% | -$2M | $31M | $572M |
| Jun '23 | $11M | -$43M | 0.0% | -378.3% | $34M | $31M | $340M |
| Mar '23 | $5M | -$39M | 0.0% | -853.8% | -$49M | $30M | $294M |
| Dec '22 | $3M | -$30M | 0.0% | -1011.3% | -$32M | $30M | $339M |
| Sep '22 | $3M | -$28M | 0.0% | -978.9% | -$9M | $30M | $361M |
| Jun '22 | $4M | -$27M | 0.0% | -623.6% | -$33M | $30M | $373M |
| Mar '22 | $4M | -$28M | 0.0% | -709.4% | -$31M | $30M | $407M |
| Dec '21 | $4M | -$18M | 0.0% | -478.0% | -$12M | $30M | $439M |
| Sep '21 | $4M | -$15M | 0.0% | -329.9% | $22M | $30M | — |
| Jun '21 | $2M | -$18M | 0.0% | -967.9% | -$13M | $30M | — |
How the market has priced BCYC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, BICYCLE THERAPEUTICS PLC's revenue has grown 47.5% per year. These are computed facts, not advice.
As of FY2025, BICYCLE THERAPEUTICS PLC reported — of total debt against $628M of cash; operating income covered interest expense -1199.3×.
In FY2025, gross margin was —, operating margin -340.4%, and net margin -301.7%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.